190 related articles for article (PubMed ID: 23291266)
1. Neuropeptide FF analog RF9 is not an antagonist of NPFF receptor and decreases food intake in mice after its central and peripheral administration.
Maletínská L; Tichá A; Nagelová V; Spolcová A; Blechová M; Elbert T; Zelezná B
Brain Res; 2013 Mar; 1498():33-40. PubMed ID: 23291266
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-releasing peptide effects in the rat brain are mediated through the Neuropeptide FF receptor.
Ma L; MacTavish D; Simonin F; Bourguignon JJ; Watanabe T; Jhamandas JH
Eur J Neurosci; 2009 Oct; 30(8):1585-93. PubMed ID: 19821834
[TBL] [Abstract][Full Text] [Related]
3. Endogenous mammalian RF-amide peptides, including PrRP, kisspeptin and 26RFa, modulate nociception and morphine analgesia via NPFF receptors.
Elhabazi K; Humbert JP; Bertin I; Schmitt M; Bihel F; Bourguignon JJ; Bucher B; Becker JA; Sorg T; Meziane H; Petit-Demoulière B; Ilien B; Simonin F
Neuropharmacology; 2013 Dec; 75():164-71. PubMed ID: 23911743
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide FF and prolactin-releasing peptide decrease cortical excitability through activation of NPFF receptors.
Buffel I; Meurs A; Portelli J; Raedt R; De Herdt V; Sioncke L; Wadman W; Bihel F; Schmitt M; Vonck K; Bourguignon JJ; Simonin F; Smolders I; Boon P
Epilepsia; 2015 Mar; 56(3):489-98. PubMed ID: 25684325
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neuropeptide FF (NPFF)-induced hypothermia and anti-morphine analgesia by RF9, a new selective NPFF receptors antagonist.
Fang Q; Wang YQ; He F; Guo J; Guo J; Chen Q; Wang R
Regul Pept; 2008 Apr; 147(1-3):45-51. PubMed ID: 18276024
[TBL] [Abstract][Full Text] [Related]
6. Effects of neuropeptide FF and related peptides on the antinociceptive activities of VD-hemopressin(α) in naive and cannabinoid-tolerant mice.
Pan JX; Wang ZL; Li N; Zhang N; Wang P; Tang HH; Zhang T; Yu HP; Zhang R; Zheng T; Fang Q; Wang R
Eur J Pharmacol; 2015 Nov; 767():119-25. PubMed ID: 26472125
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications.
Pineda R; Garcia-Galiano D; Sanchez-Garrido MA; Romero M; Ruiz-Pino F; Aguilar E; Dijcks FA; Blomenröhr M; Pinilla L; van Noort PI; Tena-Sempere M
Endocrinology; 2010 Apr; 151(4):1902-13. PubMed ID: 20160130
[TBL] [Abstract][Full Text] [Related]
8. Microinjection of RFRP-1 in the central nucleus of amygdala decreases food intake in the rat.
Kovács A; László K; Gálosi R; Tóth K; Ollmann T; Péczely L; Lénárd L
Brain Res Bull; 2012 Sep; 88(6):589-95. PubMed ID: 22691952
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide FF receptors as novel targets for limbic seizure attenuation.
Portelli J; Meurs A; Bihel F; Hammoud H; Schmitt M; De Kock J; Utard V; Humbert JP; Bertin I; Buffel I; Coppens J; Tourwe D; Maes V; De Prins A; Vanhaecke T; Massie A; Balasubramaniam A; Boon P; Bourguignon JJ; Simonin F; Smolders I
Neuropharmacology; 2015 Aug; 95():415-23. PubMed ID: 25963417
[TBL] [Abstract][Full Text] [Related]
10. Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice.
Moulédous L; Barthas F; Zajac JM
Neuropeptides; 2010 Oct; 44(5):453-6. PubMed ID: 20554321
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice.
Wang YQ; Guo J; Wang SB; Fang Q; He F; Wang R
Peptides; 2008 Jul; 29(7):1183-90. PubMed ID: 18406009
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide FF receptor antagonist, RF9, attenuates the fever induced by central injection of LPS in mice.
Wang YQ; Wang SB; Ma JL; Guo J; Fang Q; Sun T; Zhuang Y; Wang R
Peptides; 2011 Apr; 32(4):702-6. PubMed ID: 21167893
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological characterization of the mouse NPFF2 receptor.
Talmont F; Moulédous L; Piedra-Garcia L; Schmitt M; Bihel F; Bourguignon JJ; Zajac JM; Mollereau C
Peptides; 2010 Feb; 31(2):215-20. PubMed ID: 19944730
[TBL] [Abstract][Full Text] [Related]
14. Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.
Kotlinska JH; Gibula-Bruzda E; Koltunowska D; Raoof H; Suder P; Silberring J
Peptides; 2012 Jan; 33(1):156-63. PubMed ID: 22197492
[TBL] [Abstract][Full Text] [Related]
15. The anti-inflammatory potential of neuropeptide FF in vitro and in vivo.
Sun YL; Zhang XY; Sun T; He N; Li JY; Zhuang Y; Zeng Q; Yu J; Fang Q; Wang R
Peptides; 2013 Sep; 47():124-32. PubMed ID: 23856454
[TBL] [Abstract][Full Text] [Related]
16. Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors.
Talmont F; Garcia LP; Mazarguil H; Zajac JM; Mollereau C
Neurochem Int; 2009 Dec; 55(8):815-9. PubMed ID: 19682524
[TBL] [Abstract][Full Text] [Related]
17. Biological properties of prolactin-releasing peptide analogs with a modified aromatic ring of a C-terminal phenylalanine amide.
Maletínská L; Spolcová A; Maixnerová J; Blechová M; Zelezná B
Peptides; 2011 Sep; 32(9):1887-92. PubMed ID: 21872625
[TBL] [Abstract][Full Text] [Related]
18. Palmitoylation of Prolactin-Releasing Peptide Increased Affinity for and Activation of the GPR10, NPFF-R2 and NPFF-R1 Receptors: In Vitro Study.
Karnošová A; Strnadová V; Holá L; Železná B; Kuneš J; Maletínská L
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445614
[TBL] [Abstract][Full Text] [Related]
19. RF313, an orally bioavailable neuropeptide FF receptor antagonist, opposes effects of RF-amide-related peptide-3 and opioid-induced hyperalgesia in rodents.
Elhabazi K; Humbert JP; Bertin I; Quillet R; Utard V; Schneider S; Schmitt M; Bourguignon JJ; Laboureyras E; Ben Boujema M; Simonnet G; Ancel C; Simonneaux V; Beltramo M; Bucher B; Sorg T; Meziane H; Schneider E; Petit-Demoulière B; Ilien B; Bihel F; Simonin F
Neuropharmacology; 2017 May; 118():188-198. PubMed ID: 28288815
[TBL] [Abstract][Full Text] [Related]
20. RF9: May it be a new therapeutic option for hypogonadotropic hypogonadism?
Sahin Z; Kelestimur H
Med Hypotheses; 2019 Jul; 128():54-57. PubMed ID: 31203909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
